Overview

Study of the Safety & Efficacy of Intravenous Acetaminophen in Pediatric Inpatients

Status:
Completed
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
Intravenous acetaminophen (IVAPAP) is safe in repeated dose, multi-day clinical use when administered at a daily dose of 40 to 75 mg/kg body weight
Phase:
Phase 3
Details
Lead Sponsor:
Mallinckrodt
Treatments:
Acetaminophen